Michael A. Metzger, Chief Executive Officer at Syndax Pharmaceuticals Inc (SNDX), sold 6,847 shares at $18.99 ($130K) on 2026-06-01, disclosed to the SEC on 2026-06-02.
Open-market sale of $130k SNDX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SNDX | SELL | 2026-02-06 | $153K | — | Filing → |
| SNDX | SELL | 2025-09-08 | $5.2M | — | Filing → |
| SNDX | SELL | 2025-07-18 | $140K | — | Filing → |